| Date | Time | Source | Headline | Symbol | Company |
| 24/02/2011 | 22:00 | Edgar (US Regulatory) | Notice of Effectiveness (EFFECT) | NYSE:KG | King Pharmaceuticals, Inc. |
| 24/02/2011 | 22:00 | Edgar (US Regulatory) | Notice of Effectiveness (EFFECT) | NYSE:KG | King Pharmaceuticals, Inc. |
| 24/02/2011 | 22:00 | Edgar (US Regulatory) | Notice of Effectiveness (EFFECT) | NYSE:KG | King Pharmaceuticals, Inc. |
| 24/02/2011 | 08:40 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
| 24/02/2011 | 08:40 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
| 24/02/2011 | 08:39 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
| 24/02/2011 | 08:39 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
| 24/02/2011 | 08:39 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
| 24/02/2011 | 08:39 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
| 24/02/2011 | 08:38 | Edgar (US Regulatory) | Post-Effective Amendment to an S-8 filing (S-8 POS) | NYSE:KG | King Pharmaceuticals, Inc. |
| 23/02/2011 | 09:06 | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:KG | King Pharmaceuticals, Inc. |
| 19/02/2011 | 08:09 | Edgar (US Regulatory) | Post-effective Amendment to an automatic shelf registration of Form S-3ASR or Form F-3ASR (POSASR) | NYSE:KG | King Pharmaceuticals, Inc. |
| 19/02/2011 | 08:07 | Edgar (US Regulatory) | Post-effective Amendment to an automatic shelf registration of Form S-3ASR or Form F-3ASR (POSASR) | NYSE:KG | King Pharmaceuticals, Inc. |
| 19/02/2011 | 08:05 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NYSE:KG | King Pharmaceuticals, Inc. |
| 19/02/2011 | 08:04 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NYSE:KG | King Pharmaceuticals, Inc. |
| 19/02/2011 | 08:04 | Edgar (US Regulatory) | Post-Effective Amendment to Registration Statement (POS AM) | NYSE:KG | King Pharmaceuticals, Inc. |
| 19/02/2011 | 08:02 | Edgar (US Regulatory) | -National Securities Exchange Report the Removal from listing and reg. of matured,redeemed or retired securities (25) | NYSE:KG | King Pharmaceuticals, Inc. |
| 16/02/2011 | 09:03 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NYSE:KG | King Pharmaceuticals, Inc. |
| 16/02/2011 | 03:57 | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NYSE:KG | King Pharmaceuticals, Inc. |
| 15/02/2011 | 11:07 | Edgar (US Regulatory) | Statement of Ownership (SC 13G) | NYSE:KG | King Pharmaceuticals, Inc. |
| 15/02/2011 | 05:52 | Edgar (US Regulatory) | Schedule 13G | NYSE:KG | King Pharmaceuticals, Inc. |
| 11/02/2011 | 06:36 | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NYSE:KG | King Pharmaceuticals, Inc. |
| 10/02/2011 | 22:08 | Edgar (US Regulatory) | Statement of Beneficial Ownership (SC 13D) | NYSE:KG | King Pharmaceuticals, Inc. |
| 10/02/2011 | 10:08 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NYSE:KG | King Pharmaceuticals, Inc. |
| 10/02/2011 | 10:07 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NYSE:KG | King Pharmaceuticals, Inc. |
| 10/02/2011 | 10:07 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NYSE:KG | King Pharmaceuticals, Inc. |
| 10/02/2011 | 10:06 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NYSE:KG | King Pharmaceuticals, Inc. |
| 10/02/2011 | 10:06 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NYSE:KG | King Pharmaceuticals, Inc. |
| 10/02/2011 | 10:04 | Edgar (US Regulatory) | Initial Statement of Beneficial Ownership (3) | NYSE:KG | King Pharmaceuticals, Inc. |
| 09/02/2011 | 01:34 | Edgar (US Regulatory) | Current report filing (8-K) | NYSE:KG | King Pharmaceuticals, Inc. |